Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received October 19, 2009
- Revision received March 24, 2010
- Accepted March 24, 2010
- Published online June 7, 2010.
Copyright & Usage
Copyright© 2010 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- BERNHARD C. DANNER1,
- VASSILIOS N. DIDILIS1,
- STEFAN WIEMEYER1,
- TOMISLAV STOJANOVIC1,
- JULIA KITZ2,
- ALEXANDER EMMERT1,
- LASZLO FÜZESI2 and
- FRIEDRICH A. SCHÖNDUBE1
- 1Department of Thoracic and Cardiovascular Surgery, University of Göttingen, 37075 Göttingen, Germany
- 2Department of Pathology, University of Göttingen, 37075 Göttingen, Germany
- Correspondence to: Bernhard C. Danner, Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Robert-Koch-Str. 40, D-37099 Göttingen, Germany. Tel: +49 551396061 or 396008, Fax: +49 551396002, e-mail: bdanner{at}med.uni-goettingen.de
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer
- A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer
- Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
- Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib